Lise Wogensen

Lise Wogensen

Auto-generated profile, based on publicly available information

Lise Wogensen

The Research Laboratory for Biochemical Pathology, The Institute of Clinical Medicine, Aarhus University, Aarhus University Hospital, Noerrebrogade 44, Bld. 3B -1, DK-8000 Aarhus C, Denmark

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 March 2005 in Circulation Research
Verified
Journal Article
Closed access
PDF file
SCSong Chai
Song Chai
QCQing Chai
Qing Chai
CDCarl C. Danielsen
Carl C. Danielsen
PHPeter Hjorth
Peter Hjorth
JNJene R. Nyengaard
Jene R. Nyengaard
LWLise Wogensen
Lise Wogensen
The arterial content of hyaluronan (HA) undergoes diffuse changes as part of the diabetic macroangiopathy. Because HA influences the phenotype of vascular cells in vitro such as proliferation, migration, and secretion, it is tempting to speculate that diabetes-induced hastened cardiovascular disease may be linked to the increased amount of HA. To explore the pathophysiological role of altered HA content in the arterial wall in vivo, we created transgenic (Tg) mice with HA overexpression in smooth muscle cells (SMCs) in large and small vessels, targeted by the α smooth-muscle-cell-actin (αSMA) promoter fused to the human hyaluronan synthase 2 (hHAS2) cDNA. RT-PCR demonstrated hHAS2 mRNA expression in the tunica media of large and small vessels. In situ hybridization confirmed that hHAS2 mRNA was targeted to the SMCs. The aortic HA content was elevated in the Tg mice, and by immunohistochemistry, it was seen that HA accumulated in the tunica media. The secretory profile of high- and low-molecular HA was similar in wild-type and Tg animals. Overproduction of HA in the aorta resulted in thinning of the elastic lamellae in Tg mice. Our data suggest that this may lead to increased mechanical stiffness and strength, as determined by controlled stretching until failure. Finally, overproduction of HA on the genetic background of the ApoE-deficient mouse strain promoted atherosclerosis development in the aorta. These results indicate that a single component of the diabetic macroangiopathy, diffuse accumulation of HA, accelerates the progression of atherosclerosis.

19 November 2015 in Atherosclerosis
Verified
Journal Article
Closed access
PDF file
KLKaren Axelgaard Lorentzen
Karen Axelgaard Lorentzen
SCSong Chai
Song Chai
Hui ChenHui Chen
Hui Chen
CDCarl Christian Danielsen
Carl Christian Danielsen
Ulf SimonsenUlf Simonsen
Ulf Simonsen
LWLise Wogensen
Lise Wogensen

15 December 2013 in Physiological Reports
Verified
Journal Article
Open access
PDF file
TKTerese Kellenberger
Terese Kellenberger
SKSøren Krag
Søren Krag
CDCarl Christian Danielsen
Carl Christian Danielsen
XWXiao-Fan Wang
Xiao-Fan Wang
JNJens Randel Nyengaard
Jens Randel Nyengaard
LWLise Wogensen
Lise Wogensen
Transforming growth factor (TGF)‐ β 1 has a pivotal role in the pathogenesis of progressive kidney diseases that are characterized by fibrosis. The main intracellular signaling pathway of TGF‐ β 1 is the Smad system, where Smad2 and Smad3 play a central role in transcriptional regulation of target genes involved in extracellular matrix (ECM) metabolism. This study analyzes the hypothesis that blockade of Smad3 attenuates the development of TGF‐ β 1‐driven renal fibrosis. This was examined in vivo in a transgenic model of TGF‐ β 1‐induced chronic kidney disease with Smad3 or without Smad3 expression and in vitro in mesangial cells and glomerular endothelial cells with Smad2/3 inhibitors or Smad3‐knockdown. Electron microscopy was used for evaluation of morphological changes, real‐time polymerase chain reaction for detection of RNA expression, and immunohistochemistry for localization of ECM components. Matrix metalloproteinase (MMP) level was assessed by gelatin zymography electrophoresis and located by in situ zymography. The results show TGF‐ β 1‐induced mesangial matrix expansion, tubulointerstitial fibrosis, and tubular basement membrane thickening that are attenuated by Smad3 deletion, whereas TGF‐ β 1‐induced glomerular basement membrane thickening is not shown. The amount and distribution profile of MMP‐2 may suggest a role of the enzyme herein. We conclude that Smad3 targeting is not exclusively beneficial as Smad3 has diverse transcriptional regulatory effects in different cell types in the kidney.

1 April 2005 in Hormone and Metabolic Research
Verified
Journal Article
Closed access
LWL. Wogensen
L. Wogensen
SKS. Krag
S. Krag
QCQ. Chai
Q. Chai
TLT. Ledet
T. Ledet
Diabetic nephropathy is one of the most common diseases leading to fibrosis and end-stage renal disease (ESRD) world wide. Under normal conditions, a delicate equilibrium exists between synthesis, composition, and removal of extracellular matrix (ECM). If this is disturbed, ECM accumulation and fibrosis may result. The fragile balance between synthesis and removal of ECM is crucial for the prognosis of glomerular as well as interstitial pathological processes. Some features may favor ECM accumulation and progression to ESRD (dialysis and transplantation), whereas other elements may favor ECM removal and resolution (recovery). Pathogenetic mechanisms and the cellular sources of ECM in the glomerular basement membrane as well as in the tubulointerstitial space are still under investigation. Among several growth factors, transforming growth factor β1 (TGF-β1) plays a major role. We consider the use of living animals necessary for our understanding of the complex biological processes that occur during the development of ESRD. The present review will discuss the glomerular as well as interstitial accumulation of ECM and the use of transgenic animals in studying the pathogenetic mechanisms with special emphasis on diabetic kidney disease and TGF-β1.